Incidence of 106TBL Lymph Node Metastasis

Precisely Estimation of the Prognostic Value of Lymph Node in ESCC

NCT04764240 ·Status: COMPLETED

Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy

NCT05420480 ·Status: NOT_YET_RECRUITING ·Phase: NA

The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma

NCT06241066 ·Status: COMPLETED

RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY

NCT05570487 ·Status: UNKNOWN

The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study

NCT05617352 ·Status: COMPLETED

Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC

NCT04973306 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;

NCT01745107 ·Status: UNKNOWN ·Phase: PHASE3

The Application of 3T MRI in Esophageal Cancer

NCT03635619 ·Status: UNKNOWN

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study

NCT05028231 ·Status: UNKNOWN

Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

NCT05628610 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

IMRT/Pemetrexed/Cisplatin in Esophageal Cancer

NCT01630174 ·Status: UNKNOWN

Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer

NCT03120572 ·Status: COMPLETED

Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer

NCT01670409 ·Status: COMPLETED ·Phase: PHASE2

Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)

NCT01807936 ·Status: COMPLETED ·Phase: NA

Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach

NCT02448979 ·Status: UNKNOWN ·Phase: PHASE3

Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence

NCT04404491 ·Status: UNKNOWN ·Phase: PHASE3

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

NCT02858206 ·Status: UNKNOWN ·Phase: PHASE2

Study of Tislelizumab in Participants With Resectable Esophageal Squamous Cell Carcinoma

NCT04974047 ·Status: COMPLETED ·Phase: PHASE2

Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma

NCT04174079 ·Status: RECRUITING ·Phase: NA

A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study

NCT06079723 ·Status: NOT_YET_RECRUITING

Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer

NCT03029793 ·Status: UNKNOWN

A Study of SBRT for OligoMetastatic ESCC

NCT03000816 ·Status: COMPLETED ·Phase: NA

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

NCT02972372 ·Status: RECRUITING ·Phase: NA

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

NCT07046221 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

ctDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma

NCT05426850 ·Status: UNKNOWN